The SCIP manual will introduce a new assessment tool designed to be compatible with 21st century advances in measurement-base care (MBC) and personalized medicine in psychiatry (PMP). The SCIP includes 18 clinician-administered and 15 self-administered reliable and validated scales covering most adult symptom domains: anxiety, obsessions, compulsions, posttraumatic stress, depression, mania, delusions, hallucinations, disorganized thoughts, aggression, negative symptoms, alcohol use, drug use, attention deficit/hyperactivity, and eating disorders. Mental health professionals (psychiatrists, psychiatry residents, psychologists, therapists, clinical social workers, counselors, nurses, nurse practitioners, physician assistants, professors, students, and mental health researchers) are the primary audience of the manual. These professionals will be able to implement SCIP scales in their practice and use the SCIP psychopathology glossary as part of the emerging science of personalized medicine psychiatry (PMP). Existing books on measures and rating scales, such as the two books above, describe different scales developed by different authors at different periods. Each scale has its own rating guidelines and training requirements, which must be followed by clinicians in order to use the scales. This demands a considerable amount of time for clinicians and can be a barrier to using the scales in practice. Even within the same psychopathology domain, many published measurement scales exist. For instance, the book published by Waters and Stephane includes 120 scales for psychosis. Among the 120 scales for psychosis, which scale(s) should the clinician choose? Our proposed manual will remove these barriers by creating simple and universal principles which allow readers to use the 33 reliable and validated SCIP scales with most adult psychiatric disorders. There will be 15 videotaped interviews available online for readers who buy the book. Readers are expected to watch the interviews in conjunction with reading the manual.

The SCIP manual will introduce a new assessment tool designed to be compatible with 21st century advances in measurement-base care (MBC) and personalized medicine in psychiatry (PMP). The SCIP includes 18 clinician-administered and 15 self-administered reliable and validated scales covering most adult symptom domains: anxiety, obsessions, compulsions, posttraumatic stress, depression, mania, delusions, hallucinations, disorganized thoughts, aggression, negative symptoms, alcohol use, drug use, attention deficit/hyperactivity, and eating disorders. Mental health professionals (psychiatrists, psychiatry residents, psychologists, therapists, clinical social workers, counselors, nurses, nurse practitioners, physician assistants, professors, students, and mental health researchers) are the primary audience of the manual. These professionals will be able to implement SCIP scales in their practice and use the SCIP psychopathology glossary as part of the emerging science of personalized medicine psychiatry (PMP). Existing books on measures and rating scales, such as the two books above, describe different scales developed by different authors at different periods. Each scale has its own rating guidelines and training requirements, which must be followed by clinicians in order to use the scales. This demands a considerable amount of time for clinicians and can be a barrier to using the scales in practice. Even within the same psychopathology domain, many published measurement scales exist. For instance, the book published by Waters and Stephane includes 120 scales for psychosis. Among the 120 scales for psychosis, which scale(s) should the clinician choose? Our proposed manual will remove these barriers by creating simple and universal principles which allow readers to use the 33 reliable and validated SCIP scales with most adult psychiatric disorders. There will be 15 videotaped interviews available online for readers who buy the book. Readers are expected to watch the interviews in conjunction with reading the manual.

This timely resource is the first handbook to give nurse practitioners guidance to prescribe, monitor, assess, educate, and advocate for patients taking psychiatric medications and promote safe practice outcomes. Written in a concise, bulleted style for quick access to critical information, this practical resource covers the key aspects of psychotropic medications used in general psychiatry, offers strategies to simplify medication decision-making, and provides evidence-based best practice recommendations to select and manage psychotropic medications. This resource begins with an overview of general pharmacological principles, a brief discussion of neurotransmitters, and covers rationale for medication use and the risks and benefits of the major classes of psychotropic medications. This is followed by information about common drugs across drug classes divided by age population. Each drug includes initial dosing and adjustments, simplified diagnostic criteria, practice management, rationale for use, black box warnings, drug interactions, identification of side effects and adverse reactions, basic lab test recommendations, treatment options, and self-management strategies. The book ends with important concepts for patient and/or caregiver education and advocacy. Tables and "Fast Facts" boxes throughout highlight key information. Chapters begin with learning objectives and include references, website resources, and recommendations for additional reading. Key Features: Follows a lifespan approach to psychiatric mental health pharmacology Provides population-specific treatment approaches for optimal medical decision-making Highlights critical information with "Fast Facts" boxes Delivers essential knowledge included in board certification exams Contains critical-thinking questions in each chapter to reinforce content

Psychiatric clinicians should use rating scales and questionnaires often, for they not only facilitate targeted diagnoses and treatment; they also facilitate links to empirical literature and systematize the entire process of management. Clinically oriented and highly practical, the Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health is an ideal tool for the busy psychiatrist, clinical psychologist, family physician, or social worker. In this ground-breaking text, leading researchers provide reviews of the most commonly used outcome and screening measures for the major psychiatric diagnoses and treatment scenarios. The full range of psychiatric disorders are covered in brief but thorough chapters, each of which provides a concise review of measurement issues related to the relevant condition, along with recommendations on which dimensions to measure – and when. The Handbook also includes ready-to-photocopy versions of the most popular, valid, and reliable scales and checklists, along with scoring keys and links to websites containing on-line versions. Moreover, the Handbook describes well known, structured, diagnostic interviews and the specialized training requirements for each. It also includes details of popular psychological tests (such as neuropsychological, personality, and projective tests), along with practical guidelines on when to request psychological testing, how to discuss the case with the assessment consultant and how to integrate information from the final testing report into treatment. Focused and immensely useful, the Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health is an invaluable resource for all clinicians who care for patients with psychiatric disorders.

Revised and updated, this practical handbook is a succinct how-to guide to the psychiatric interview. In a conversational style with many clinical vignettes, Dr. Carlat outlines effective techniques for approaching threatening topics, improving patient recall, dealing with challenging patients, obtaining the psychiatric history, and interviewing for diagnosis and treatment. This edition features updated chapters on the major psychiatric disorders, new chapters on the malingering patient and attention-deficit hyperactivity disorder, and new clinical vignettes. Easy-to-photocopy appendices include data forms, patient education handouts, and other frequently referenced information. Pocket cards that accompany the book provide a portable quick-reference to often needed facts.

In order to accurately describe and diagnose psychiatric illness, practitioners require in-depth knowledge of the signs and symptoms of behavioral disorders. Descriptive Psychopathology provides a broad review of the psychopathology of psychiatric illness, beyond the limitations of the DSM and ICD criteria. Beginning with a discussion of the background to psychiatric classification, the authors explore the problems and limitations of current diagnostic systems. The following chapters then present the principles of psychiatric examination and diagnosis, described with accompanying patient vignettes and summary tables, and related to different diagnostic concerns. A thought-provoking conclusion proposes a restructuring of psychiatric classification based on the psychopathology literature and its validating data. Written for psychiatry and neurology residents, as well as clinical psychologists, it is invaluable to anyone who accepts the responsibility for the care of patients with behavioral syndromes.

Produced as a partnership between the American Psychiatric Association and the National Institute of Mental Health, the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse, this thought-provoking collection of white papers: Examines nomenclature issues. Reviews genetic, brain imaging, postmortem, and animal model research and includes strategic insights for a new research agenda Outlines recent progress in developmental neuroscience, genetics, psychology, psychopathology, and epidemiology, focusing on the turbulent first two decades of life. Suggests a research agenda for personality disorders that uses a dimensional rather than the current categorical approach to diagnosis. Proposes a research agenda to evaluate the clinical utility and validity of adding relational disorders to DSM-IV. Reevaluates the relationship between mental disorders and disability, proposing that diagnosis and disability be uncoupled. Examines the importance of culture in psychopathology and the main cultural variables at play in the diagnostic process.

The positive versus negative distinction of schizophrenic disorders has pro moted ongoing research. Phenomenology, psychopathology, biology, genet ics, pharmacological and nonpharmacological treatment, psychosocial and longitudinal research: all have found a new focus of interest. This volume attempts to provide an unbiased picture of the status of American and Eu ropean knowledge regarding the positive/negative distinction. Researchers from North America and Europe describe the relation of modern concepts of positive and negative symptomatology to the original models of Rey nolds and Jackson. Integrating phenomenological, genetic, and biological factors, the authors depict current methods of assessing positive and nega tive symptomatology, differentiating between primary and secondary symp tomatology, and using pharmacological and nonpharmacological treatment. The stability of positive and negative symptoms over time and evidence for the occurrence of separate positive and negative episodes over a long-term course of schizophrenia are extensively discussed in terms of their implica tions on the positive/negative construct. The relevance of the positive/nega tive dichotomy to child and adolescent schizophrenia is also debated. The main aim of this book is not to advocate a single concept and present only arguments supporting it, but to discuss important controversies. Prob lems concerning a concept cannot be solved by ignoring them. However, unanswered questions may be resolved through discussion, debate, and con structive compromise.